search
Back to results

The Beans to Enrich the Gut Microbiome vs. Obesity's Negative Effects (BE GONE) Trial

Primary Purpose

Colorectal Cancer Prevention

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Regular Diet
Navy Beans (Canned)
Sponsored by
M.D. Anderson Cancer Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Colorectal Cancer Prevention focused on measuring Cancer Prevention, Precancerous colorectal polyps, Canned beans, Questionnaires, Surveys, Stool samples

Eligibility Criteria

30 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Adult men and women 30+ years of age
  2. Meet criteria for overweight or obesity via BMI or waist size
  3. Underwent colonoscopy screening within the past 10 years
  4. History of pathology-confirmed precancerous polyp of the colon or rectum; OR Colorectal cancer survivor who has completed treatment with adequate maintenance of bowel length (eligible: hemicolectomy or low anterior resection; ineligible: total or near total colectomy, greater than 10 cm of small bowel resection) and normalized bowel habits
  5. English-speaking and reside in the greater Houston/outlying areas and/or willing to travel for study-related visits at MD Anderson
  6. Ability to complete web-based dietary assessments twice per week
  7. Willingness to provide stool samples and undergo venipuncture
  8. Willingness to consume/avoid beans as instructed during the 16 weeks from randomization

Exclusion Criteria:

  1. Antibiotic use in the past month and unable/unwilling to be deferred to a later recruitment date
  2. Current smoker
  3. Heavy drinker (defined as more than 14 drinks per week)
  4. Currently taking exclusionary prescription medications (including cytokines, immunosuppressive agents, chemopreventive drugs, bile acid sequestrants/selective cholesterol absorption inhibitors)
  5. Regularly taking anti flatulence medications, probiotics and/or fiber supplements and unable/unwilling to discontinue for the purpose of the study
  6. Major dietary restrictions relevant to the intervention
  7. Hereditary colorectal cancer syndromes
  8. Pregnant or lactating or planning to become pregnant

Sites / Locations

  • University of Texas MD Anderson Cancer Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Regular Diet + Beans, Then Regular Diet - Beans

Regular Diet - Beans, Then Regular Diet + Beans

Arm Description

Outcomes

Primary Outcome Measures

Changes in Stool 16S rRNA Gene Profiles
The primary outcome measures will be intra- and inter-individual changes in stool 16S rRNA gene profiles at baseline, week 4 and week 8 for each cross-over period.
Changes in Blood Markers and Metabolites
The primary outcome measures will be intra- and inter-individual changes in blood makers and metabolites at baseline, week 8 for each cross-over period.

Secondary Outcome Measures

Full Information

First Posted
July 18, 2016
Last Updated
October 2, 2023
Sponsor
M.D. Anderson Cancer Center
search

1. Study Identification

Unique Protocol Identification Number
NCT02843425
Brief Title
The Beans to Enrich the Gut Microbiome vs. Obesity's Negative Effects (BE GONE) Trial
Official Title
The Beans to Enrich the Gut Microbiome vs. Obesity's Negative Effects (BE GONE) Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
July 25, 2016 (Actual)
Primary Completion Date
July 31, 2025 (Anticipated)
Study Completion Date
July 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
M.D. Anderson Cancer Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
You are being asked to take part in this study because either you are a survivor who has a previous history of colorectal cancer or an MD Anderson patient who had a precancerous colorectal polyp or you have a previous history of colorectal cancer, and you have a current adult body mass index (BMI) score of 25 or higher. The BMI score is used as an indicator of the level of body fat, based on height and weight. The goal of this clinical research study is to learn if eating canned, pre-cooked beans can help improve the levels of healthy bacteria in the digestive system and reduce the effects of obesity on cancer risk. This is an investigational study. Up to 80 participants will be enrolled in this study. All will take part at MD Anderson.
Detailed Description
Study Groups: If you are found to be eligible, you will be randomly assigned (as in the flip of a coin) to 1 of 2 study groups (intervention or control). This is done because no one knows if one study group is better, the same, or worse than the other group. Both groups will be given a diet to follow for 8 weeks. Intervention group participants will add canned beans into their diets beginning at ½ cup per day. This will be increased to 1 cup per day during the first 2 weeks, and then will continue at 1 cup per day for the following 6 weeks of the study. You will be asked to keep a log of your bean consumption during this time. Control group participants will be instructed to follow their normal diet (not including beans) for 8 weeks. Length of Study: Your active participation on the study will last a total of 20 weeks. Your participation on the study will be over after the follow-up period. Long-Term Follow-Up: Up to 2 times each year for up to 5 years, a member of the study staff will contact you and ask about how you are doing. You will be contacted by phone, email, or standard mail. These calls will last 15-20 minutes each. At 6 months and 1 year after your last visit, you will complete the same questionnaires you completed at screening. Study Visits: At each visit, your waist measurements and weight will be collected. Every 4 weeks (Visits 2, 3, 4, 5, and 6), blood (about 3 tablespoons) will be drawn for routine tests. You will be asked to bring a stool sample to each visit and mail a stool sample at the end of week 1 during the intervention. You will be provided with a container and instructions to collect each stool sample. You may send your stool sample back to the study staff by mail. If you choose to send it by mail, you will be given a pre-paid envelope for this. At Visit 4, your study group assignment will be switched, and you will be assigned to the opposite group and diet from your first assignment (meaning intervention group members will be switched to the control group as well as the other way around). You will follow this new diet for the remaining 8 weeks.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colorectal Cancer Prevention
Keywords
Cancer Prevention, Precancerous colorectal polyps, Canned beans, Questionnaires, Surveys, Stool samples

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
71 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Regular Diet + Beans, Then Regular Diet - Beans
Arm Type
Experimental
Arm Title
Regular Diet - Beans, Then Regular Diet + Beans
Arm Type
Active Comparator
Intervention Type
Other
Intervention Name(s)
Regular Diet
Intervention Description
Participants follow their normal diet (not including beans for 8 weeks)
Intervention Type
Other
Intervention Name(s)
Navy Beans (Canned)
Other Intervention Name(s)
Canned Beans
Intervention Description
Participants add 1/2 cup of canned beans per day to their diets for the first 2 weeks. This is increased to 1 cup per day for the following 6 weeks of the study.
Primary Outcome Measure Information:
Title
Changes in Stool 16S rRNA Gene Profiles
Description
The primary outcome measures will be intra- and inter-individual changes in stool 16S rRNA gene profiles at baseline, week 4 and week 8 for each cross-over period.
Time Frame
Baseline to week 8
Title
Changes in Blood Markers and Metabolites
Description
The primary outcome measures will be intra- and inter-individual changes in blood makers and metabolites at baseline, week 8 for each cross-over period.
Time Frame
Baseline to week 8

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult men and women 30+ years of age Meet criteria for overweight or obesity via BMI or waist size Underwent colonoscopy screening within the past 10 years History of pathology-confirmed precancerous polyp of the colon or rectum; OR Colorectal cancer survivor who has completed treatment with adequate maintenance of bowel length (eligible: hemicolectomy or low anterior resection; ineligible: total or near total colectomy, greater than 10 cm of small bowel resection) and normalized bowel habits English-speaking and reside in the greater Houston/outlying areas and/or willing to travel for study-related visits at MD Anderson Ability to complete web-based dietary assessments twice per week Willingness to provide stool samples and undergo venipuncture Willingness to consume/avoid beans as instructed during the 16 weeks from randomization Exclusion Criteria: Antibiotic use in the past month and unable/unwilling to be deferred to a later recruitment date Current smoker Heavy drinker (defined as more than 14 drinks per week) Currently taking exclusionary prescription medications (including cytokines, immunosuppressive agents, chemopreventive drugs, bile acid sequestrants/selective cholesterol absorption inhibitors) Regularly taking anti flatulence medications, probiotics and/or fiber supplements and unable/unwilling to discontinue for the purpose of the study Major dietary restrictions relevant to the intervention Hereditary colorectal cancer syndromes Pregnant or lactating or planning to become pregnant
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carrie Daniel-MacDougall, PHD
Organizational Affiliation
M.D. Anderson Cancer Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Texas MD Anderson Cancer Center
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
31852462
Citation
Zhang X, Browman G, Siu W, Basen-Engquist KM, Hanash SM, Hoffman KL, Okhuysen PC, Scheet P, Petrosino JF, Kopetz S, Daniel CR. The BE GONE trial study protocol: a randomized crossover dietary intervention of dry beans targeting the gut microbiome of overweight and obese patients with a history of colorectal polyps or cancer. BMC Cancer. 2019 Dec 18;19(1):1233. doi: 10.1186/s12885-019-6400-z.
Results Reference
derived
Links:
URL
http://www.mdanderson.org
Description
University of Texas MD Anderson Cancer Center Website

Learn more about this trial

The Beans to Enrich the Gut Microbiome vs. Obesity's Negative Effects (BE GONE) Trial

We'll reach out to this number within 24 hrs